How Will Artificial Intelligence Contribute to the Life Sciences?

Artificial Intelligence (AI) can advance the Florida life sciences industry in a number of ways as well as augment existing processes to improve them and expedite them. However, it’s not without its challenges. One of the biggest difficulties life sciences professionals face is explaining how AI came to a particular conclusion.

For example, AI can compare data sets and cross-reference infinite resources to determine that a patient is suffering from a specific type of cancer. While identifying and treating a condition quickly is obviously a positive thing, oncologists have a hard time explaining how they know the patient has cancer. Since AI determined the result and the physician can’t explain how the AI identified the illness, patients maintain a significant degree of distrust for the technology.

While the oncologist may have faith in the AI’s diagnosis since it drew the conclusion from data sets the oncologist provided, many patients won’t have confidence in the outcome. Until the life sciences industry can untangle how AI makes diagnoses or explain it in such a way that is acceptable to the patient, it will be some time before machines will deliver medical analyses.

Uses for AI in the Life Sciences Sector

While progress is inevitable, it will take time for public opinion to accept diagnoses from intelligent machines. In the meantime, however, there are a variety of ways that AI is making strides in the life sciences industry:

  1. Helping scientists ensure exact measurements consistently for liquid medications to remove human error when developing new drug therapies.
  2. Reducing redundancy and avoiding drug contraindications for new therapies with improved research capabilities.
  3. Comparing data to help marketers hone their audience as well as improve engagement with healthcare professionals.
  4. Detecting cancers or warning signs of cancers to start drug therapies sooner and improve patient outcomes. While it will be some time before patients accept a machine’s diagnosis at face value, many accept that AI can detect markers for cancer in their bloodstream.

New and exciting changes are coming to the Florida life science industry, but they aren’t without their risks. While smart machines and AI can advance life sciences organizations and facilities, the outcomes often hold human lives in the balance. To learn more about managing risks in a progressive industry, contact the experts at MMA Florida.